The mental health consequences of nonmedical prescription drug use among adolescents

Journal of Mental Health Policy and Economics

Volumn 18, Issue 1, 2015, Pages 3-15

  Ali, Mir M ^a   Dean, David ^a   Lipari, Rachel ^a   Dowd, William N ^b   Aldridge, Arnie P ^b   Novak, Scott P ^b  

^a SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PRESCRIPTION DRUG; NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG MISUSE; DSM-IV; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MENTAL HEALTH; OUTCOME ASSESSMENT; PROPENSITY SCORE; PSYCHOLOGICAL INTERVIEW; SOCIAL STATUS; SUBSTANCE USE; AGE; CHILD; DEPRESSIVE DISORDER, MAJOR; PSYCHOLOGY; SEX DIFFERENCE; SOCIOECONOMICS; SUBSTANCE-RELATED DISORDERS;

ADOLESCENT; AGE FACTORS; ANALGESICS, OPIOID; CHILD; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MENTAL HEALTH; SEX FACTORS; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 84930249184     PISSN: 10914358     EISSN: 1099176X     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. 2013.
2. Monitoring the Future. A Synopsis of the 2009 Results of Trends in Teen Use of Illicit Drugs and Alcohol. 2009.
3. Office of National Drug Control Policy. Epidemic: Responding to America's Prescription Drug Abuse Crisis. 2011.
4. National Institute on Drug Abuse. Prescription Drugs: Abuse and Addiction. 2011.
5. Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 2006; 81(2):103-107.
6. Squeglia LM, Jacobus J, Tapert SF. The influence of substance use on adolescent brain development. Clin EEG Neurosci. 2009; 40(1):31-38.
7. Compton WM, Volkow ND. Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend. 2006; 83:S4-S7.
8. Kandel DB, Yamaguchi K, Chen K. Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory. J Stud Alcohol 1992; 53(5):447-457.
9. McCabe SE, West BT, Morales M, Cranford JA, Boyd CJ. Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study. Addiction 2007; 102(12):1920-1930.
10. Sullivan MD, Edlund MJ, Zhang L, Unutzer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med 2006; 166(19):2087-2093.
11. Popovici I, Lai L, Lopez-Evangelio F. Non-Medical Use of Prescription Drugs and Health Services Utilization. Journal of Developing Drugs. 2013; 2(104).
12. Kotecha M, Sites B. Pain policy and abuse of prescription opioids in the USA: A cautionary tale for Europe. Anaesthesia 2013; 68(12):1210-1215.
13. Chatterji P, Alegria M, Takeuchi D. Psychiatric disorders and labor market outcomes: Evidence from the National Comorbidity Survey- Replication. J Health Econ 2011; 30(5):858-868.
14. Ettner SL. The relationship between labor market outcomes and physical and mental health - Exogenous human capital or endogenous health production? Research in Human Capital and Development, . 2000; 13:1-31.
15. Wilcox-Gok V, Marcotte DE, Farahati F, Borkoski CE. Early onset depression and high school dropout. Economics of Gender and Mental Illness. 2004;15:27-51.
16. Inturrisi CE. Clinical pharmacology of opioids for pain. Clin J Pain 2002; 18(4 Suppl): 3-13.
17. Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK. Opioids for Chronic Noncancer Pain: Prediction and Identification of Aberrant Drug-Related Behaviors: A Review of the Evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice Guideline. J Pain 2009; 10(2):131-146.
18. Pilcher C, Browne JL. Hyperalgesia produced by intrathecal opioid antagonists depends on receptor selectivity and noxious stimulus. NIDA Res Monogr 1985;75:469-472.
19. Raffa RB, Pergolizzi JV Jr. Opioid-induced hyperalgesia: is it clinically relevant for the treatment of pain patients? Pain Manag Nurs. 2013; 14(3): 67-83.
20. Dahl RE. Adolescent brain development: A period of vulnerabilities and opportunities - Keynote address. In: Dahl RE, Spear LP, editors. Adolescent Brain Development: Vulnerabilities and Opportunities. Annals of the New York Academy of Sciences. 2004; p. 1-22.
21. Southwick SM, Vythilingam M, Charney DS. The psychobiology of depression and resilience to stress: implications for prevention and treatment. Annu Rev Clin Psychol 2005; 1:255-291.
22. Martins SS, Fenton MC, Keyes KM, Blanco C, Zhu H, Storr CL. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychol Med 2012; 42(6):1261-1272.
23. Lo CC, Monge AN, Howell RJ, Cheng TC. The Role of Mental Illness in Alcohol Abuse and Prescription Drug Misuse: Gender-Specific Analysis of College Students. J Psychoactive Drugs 2013; 45(1):39-47.
24. Austin PC. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate Behav Res 2011; 46(3):399-424.
25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV: Amer Psychiatric Pub Inc; 1994.
26. De Simone J. Drinking and academic performance in high school. Applied Economics. 2010; 42(12):1481-1497.
27. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70(1):41-55.
28. Smith JA, Todd PE. Reconciling conflicting evidence on the performance of propensity-score matching methods. Am Econ Rev 2001; 91(2):112-118.
29. Lunceford JK, Davidian M. Stratification and weighting via the propensity score in estimation of causal treatment effects: A comparative study. Stat Med 2004; 23(19):2937-2960.
30. Morgan SL, Todd JJ. A diagnostic routine for the detection of consequential heterogeneity of causal effects. In: Xie Y, editor. Sociol Methodol. Sociological Methodology. 2008; p. 231-281.
31. Eisenhower D, Mathiowetz NA, Morganstein D. Recall error: Sources and bias reduction techniques. In: Biemer PP, Groves RM, Lyberg LE, Mathiowetz NA, Sudman S, editors. Measurement errors in surveys. 1991; p. 125-144.
32. Golub A, Johnson BD, Labouvie E. On correcting biases in self-reports of age at first substance use with repeated cross-section analysis. J Quant Criminol 2000; 16(1):45-68.
33. StataCorp. Stata Statistical Software: Release 13. College Station, TX. 2013.
34. Dehejia RH, Wahba S. Propensity score-matching methods for nonexperimental causal studies. Rev Econ Stat 2002; 84(1):151-161.
35. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2 ed. New York, NY: John Wiley & Sons, Inc.; 2000.
36. He H, McDermott MP. A robust method using propensity score stratification for correcting verification bias for binary tests. Biostatistics 2012; 13(1):32-47.
37. Becker SO, Ichino A. Estimation of average treatment effects based on propensity scores. The State Journal 2002; 2(4):358-377.
38. Austin PC. Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research. Communications in Statistics-Simulation and Computation. 2009; 38(6):1228-1234.
39. Ho DE, Imai K, King G, Stuart EA. Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Political Analysis 2007; 15(3):199-236.
40. Imai K, King G, Stuart EA. Misunderstandings between experimentalists and observationalists about causal inference. Journal of the royal statistical society: series A (statistics in society). 2008;171(2):481-502.
41. Cohen J. Statistical power analysis for the behavioral sciencies: Routledge; 1988.
42. Pocock SJ, Assmann SE, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practiceand problems. Stat Med 2002; 21(19):2917-2930.
43. McCabe SE, Boyd CJ, Cranford JA, Teter CJ. Motives for Nonmedical Use of Prescription Opioids Among High School Seniors in the United States Self-Treatment and Beyond. Arch Pediatr Adolesc Med 2009; 163(8):739-744.
44. Kandel DB, Davies M, Karus D, Yamaguchi K. The Consequences in Young Adulthood of Adolescent Drug Involvement: An Overview. Arch Gen Psychiatry 1986; 43(8):746-754.
45. Toumbourou JW, Stockwell T, Neighbors C, Marlatt GA, Sturge J, Rehm J. Adolescent health 4 - Interventions to reduce harm associated with adolescent substance use. Lancet 2007; 369(9570):1391-1401.
46. Ali MM, Ajilore O. Can Marriage Reduce Risky Health Behavior for African-Americans? Journal of Family and Economic Issues 2011; 32(2):191-203.
47. Anderson DM, Cesur R, Tekin E. Youth Depression and Future Criminal Behavior. NBER Working Papers. 2012.
48. Hawkins JD, Catalano RF, Miller JY. Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention. Psychol Bull 1992; 112(1):64.
49. Skara S, Sussman S. A review of 25 long-Term adolescent tobacco and other drug use prevention program evaluations. Prev Med 2003; 37(5):451-474.
50. Manchikanti L. National drug control policy and prescription drug abuse: facts and fallacies. Pain Physician 2007; 10(3):399.
51. Spoth R, Trudeau L, Shin C, Ralston E, Redmond C, Greenberg M, et al. Longitudinal Effects of Universal Preventive Intervention on Prescription Drug Misuse: Three Randomized Controlled Trials With Late Adolescents and Young Adults. Am J Public Health. 2013; 103(4):665-672.